Mérieux Alliance Becomes Institut Mérieux

Alain Mérieux Confirms the Institute';s Commitment to Meeting new Medical and Public Health Challenges

09-Dec-2009 - France

Mérieux Alliance, the Mérieux family holding company, announced that it changes its name to take on the historic name of Institut Mérieux. At a press conference held in Paris, Alain Mérieux reviewed the important role played by industrial biology in the face of major public health challenges including infectious diseases, cancer, personalized medicine, theranostics and nutrition. Along with Alexandre Mérieux and the management teams, he outlined the many strengths that Institut Mérieux and its companies - bioMérieux, Transgene, ABL and Silliker - will rely upon to meet these challenges in three strategic areas: in vitro diagnostics, immunotherapy , food safety and nutrition.

"Today we are returning to a name with historic value: the name Institut Mérieux, created in 1897 by Marcel Mérieux. We are especially attached to the symbol this name represents, but above all it is a flag for our commitment to serving the medicine of tomorrow," said Alain Mérieux. "Now more than ever, we intend to serve public health globally. This flag stands for longstanding values that are as relevant today as they were yesterday: the long-term vision that is essential for our bio-industrial activities, a resolutely global approach, and growth driven by scientific innovation, upholding the family and Pasteurian tradition."

Institut Mérieux plans to mobilize all the scientific, industrial and financial resources necessary to carry out its missions to serve medicine and public health worldwide. Following the sale last August of the ShanH holding, which controlled the Indian vaccine company Shantha Biotechnics, the Institute has concentrated on the development of three key areas of activity, with an emphasis on scientific innovation and an international presence.

https://www.bionity.com/en/news/110574/merieux-alliance-becomes-institut-merieux.html